United States · FDA National Drug Code directory
Imatinib
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43598-344_38a9944b-db90-72f2-3f0b-7767da490ae2
- Product NDC
- 43598-344
- Form
- TABLET
- Composition / generic term
- Imatinib
- Labeler
- Dr.Reddy's Laboratories Inc
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180813
- Source listing expiry
- 20261231
Source-listed ingredients
- IMATINIB MESYLATE — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1000 TABLET in 1 CONTAINER (43598-344-10) · 43598-344-10
- 30 TABLET in 1 CONTAINER (43598-344-30) · 43598-344-30
- 3 BLISTER PACK in 1 CARTON (43598-344-31) / 10 TABLET in 1 BLISTER PACK · 43598-344-31
- 90 TABLET in 1 CONTAINER (43598-344-90) · 43598-344-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →